Medical and Pharmaceutical Industry - Market Research Report

The global   pharmaceutical market   size was estimated at USD 1,645.75 billion in 2024 and is projected to reach USD 2,350.43 billion by 2030, expanding at a CAGR of 6.12% from 2025 to 2030. This growth is primarily driven by the increasing prevalence of chronic diseases, an aging global population, and rising healthcare expenditures. Advancements in biologics, personalized medicine, and RNAi-based therapeutics are significantly improving treatment outcomes. Accelerated regulatory pathways and a growing focus on patient-centric healthcare solutions are further contributing to market expansion. Technological progress in drug delivery systems and wider access to healthcare in emerging regions also support this upward trajectory. Additionally, strategic partnerships and continuous R&D investments are critical in driving product innovation and sustaining competitive advantages. The pharmaceutical market has witnessed remarkable advancements due to a robust pipeline and signif...

The global   pharmaceutical contract manufacturing market   size was estimated at USD 129,186.7 million in 2024 and is projected to reach USD 224,510.6 million by 2030, growing at a CAGR of 9.8% from 2025 to 2030. As the pharmaceutical industry continues to evolve rapidly, companies are increasingly relying on external partners such as contract manufacturing organizations (CMOs) to support efficient and cost-effective drug production. The expansion of this market is largely driven by the rising costs of drug development, increasing demand for pharmaceutical drugs, and the growing integration of advanced technologies within CMO production facilities. CMOs primarily offer contract-based drug manufacturing services based on the formulas provided by pharmaceutical companies, ensuring efficient and streamlined production processes. These partnerships enable pharmaceutical companies to minimize capital expenditures and operational costs, accelerating the drug development cycle and h...

The global   peptide synthesis market   size was estimated at USD 961.5 million in 2024 and is projected to reach USD 1,840.6 million by 2033, growing at a CAGR of 7.71% from 2025 to 2033. This notable growth is attributed to the rising demand for peptide-based therapeutics, ongoing technological advancements in synthesis methods, and the broadening scope of applications across pharmaceutical and biotechnology sectors. A major driver of growth in the peptide synthesis market is the expanding adoption of peptide-based therapeutics. Peptides offer an optimal blend of high specificity, minimal toxicity, and excellent biocompatibility, making them particularly effective in managing chronic and lifestyle-related conditions such as cancer, diabetes, obesity, and cardiovascular diseases. Innovations in peptide stability, delivery mechanisms, and reduced immunogenic profiles have led to a growing number of FDA-approved peptide drugs and a surge in clinical development activities. The ...

The global   pediatric hospitals market   size was estimated at USD 160.44 billion in 2023 and is projected to reach USD 236.03 billion by 2030, growing at a CAGR of 5.68% from 2024 to 2030. This significant growth is primarily driven by the increasing pediatric population, rising income levels, and a growing preference among parents for seeking care from super-specialists. Additionally, rapid advancements in digital health systems are further supporting market expansion. A major factor propelling the market is the rising incidence of pediatric diseases worldwide. The growing demand for specialized pediatric services aligns with the ongoing development of the hospital sector. Increasing investments in pediatric healthcare, particularly in research and treatment for rare diseases, are expected to further stimulate market growth. For instance, in June 2023, Children's National Hospital received a substantial USD 96 million donation from an anonymous family to support research an...

  The global   mortuary equipment market   size was estimated at USD 1.11 billion in 2024 and is projected to reach USD 1.55 billion by 2030, expanding at a CAGR of 5.6% from 2025 to 2030. This growth is primarily driven by the rising death rates, which have resulted in a heightened demand for essential mortuary equipment such as body bags, refrigeration units, and autopsy tables. The increase in mortality rates has highlighted the urgent requirement for improved mortuary services and related equipment, thereby positioning the market for substantial expansion. According to the World Population Review 2023, the population of individuals aged 65 and above in Least Developed Countries (LDCs) is expected to grow at a significantly faster pace than in Other Developing Countries (ODCs). Between 2023 and 2050, the older adult population in LDCs is projected to nearly triple, while ODCs will experience more than a twofold increase in the same timeframe. This demographic shift is ...

  The global   military wearable medical devices market   size was estimated at USD 7.45 billion in 2023 and is projected to reach USD 38.77 billion by 2030, growing at a CAGR of 26.3% from 2024 to 2030. A key factor driving this market is the increasing investment in research and development of advanced military technologies focused on soldier safety and health monitoring. The market growth is further supported by the growing dependence on real-time physiological data collection, such as heart rate, blood pressure, oxygen saturation, and body temperature. These vital signs are critical for assessing a soldier's physical condition and ensuring immediate medical intervention during field missions. Rising global conflicts have escalated the demand for military wearable medical devices that enable health tracking for soldiers deployed in various terrains. These devices are typically compact, lightweight, and integrated with wireless cloud connectivity, reducing the physical ...

  The   Middle East & Africa (MEA) diabetes care devices market   was valued at USD 1.03 billion in 2023 and is anticipated to grow at a CAGR of 8.20% from 2024 to 2030. This growth is largely attributed to the increasing prevalence of diabetes across the region, influenced by evolving lifestyles and associated health issues. Diabetic patients must consistently monitor and manage their blood glucose levels, requiring routine use of insulin or carbohydrate intake adjustments. As diabetes becomes a mounting healthcare concern, the demand for effective diabetes management tools continues to grow. According to the International Diabetes Federation (IDF) MENA Region, in 2021, approximately 73 million people aged 20–79 were living with diabetes, a number expected to rise to 95 million by 2030. Additionally, 48 million individuals in the region had impaired glucose tolerance, increasing their risk of developing type 2 diabetes. Diabetes-related fatalities reached 796,000, an...